Heart Failure and Wide QRS: Clinical and Pharmacological Perspectives
Alfredo Mauriello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Vincenzo Russo(University of Catania), Pierpaolo Di Micco, Martina Grieco(Ospedale San Giovanni Bosco), Egidio Imbalzano(University of Messina), Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Antonello D’Andrea(University of Campania "Luigi Vanvitelli"), Francesco Giallauria(National Institute on Aging), Antonia Ascrizzi(University of Campania "Luigi Vanvitelli"), Gerardo Elia Del Vecchio, Adriana Correra(Ospedali Riuniti di Foggia), Arianna Amata(Agostino Gemelli University Polyclinic), Mariano Paternoster(Federico II University Hospital)
Cited by 5
Related Papers
New loci associated with kidney function and chronic kidney disease
|Nature Genetics|2010|809
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension
|International Journal of Cardiology|2013|242
Association between left ventricular structure and cardiac performance during effort in two morphological forms of athlete’s heart
|International Journal of Cardiology|2002|130
Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension
|CHEST Journal|2016|122